Raymond James analyst Wilma Burdis raised the firm’s price target on Aflac (AFL) to $119 from $110 and keeps an Outperform rating on the shares. The firm’s higher 2026 and 2027 EPS estimates reflect the company’s update in Q3 that result in stronger earnings power seen in 2026 and beyond, the analyst tells investors.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AFL:
- Aflac says 22.6M people impacted by June hack, TechCrunch reports
- Aflac price target raised to $102 from $100 at TD Cowen
- Ethos, Aflac partner to bring supplemental health product suite to distribution
- Aflac initiated with an Underperform at Mizuho
- Aflac price target raised to $120 from $118 at Morgan Stanley